| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Options Exercise | $5.22M | +136K | +157.89% | $38.40 | 222K | Aug 27, 2021 | Direct | F1 |
| transaction | ABT | Common shares without par value | Sale | -$17.1M | -136K | -61.22% | $125.48 | 86.1K | Aug 27, 2021 | Direct | F2 |
| holding | ABT | Common shares without par value | 1.54K | Aug 27, 2021 | Profit Sharing Trust | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Option (right to buy) | Options Exercise | $0 | -136K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Shares | 136K | $38.40 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Includes shares acquired pursuant to a dividend reinvestment feature. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.96 to $125.72, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | Balance in the Abbott Laboratories Stock Retirement Trust as of August 27, 2021. |
| F4 | Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).